Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer

By afschroeder • October 14, 2025

Chan AA, Sankar K, Reckamp KL, Díaz B, Lee DJ. Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer. Sci Rep. 2025 Oct 13;15(1):35597. doi: 10.1038/s41598-025-11897-9. PMID: 41083501.

Tags: Cedars Sinai DoM, Dermatology, Harbor UCLA, Hematology/Oncology, Lung adenocarcinoma, NMT1, Publications, survival, The Cancer Genome Atlas, TIMM17A

Temporal Changes in Quality of Life in Patients with alcohol-associated Acute Pancreatitis

Kadi T, Zheng Y, Papachristou GI, Buxbaum JL, Pisegna JR, Pandol SJ, Adeniran E, Rothenberger S, Jeon CY, Yadav D. Temporal Changes in Quality of[...]

Uptake, Geographic Access, and Outcomes of Transcatheter Mitral Valve Repair in the United States

Watanabe A, Ueyama HA, Miyamoto Y, Gotanda H, Kaneko T, Latib A, Kolte D, Baron SJ, Secemsky E, Laham RJ, Tsugawa Y, Kuno T. Uptake,[...]

Ferumoxytol-Enhanced Cardiovascular Magnetic Resonance Imaging: Applications and Technical Advances

Nguyen KL, Loke YH, Li JM, Bedayat A, Yang HJ, Xie Y, Christodoulou AG, Li D, Zhong X, Finn JP. Ferumoxytol-Enhanced Cardiovascular Magnetic Resonance Imaging:[...]